Contact Us

Get 30% Free Customization on This Report

Published Date: June, 2019

Human Papillomavirus Vaccine Market (Product Type - Gardasils, Gardasil 9, and Cervarix; Indication - Cervical Cancer, Cancer, Vaginal Cancer, Vulvar Cancer, Oropharyngeal Cancer, and Other Indications; Distribution Channel - Hospitals, Clinics, and Government Entities): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025


Request Discount Enquire Before Buying

A recent report published by Infinium Global Research on human papillomavirus vaccine market provides an in-depth analysis of segments and sub-segments in the global as well as regional human papillomavirus vaccine market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional human papillomavirus vaccine market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global human papillomavirus vaccine market. According to the report, the global human papillomavirus vaccine market is projected to grow at a CAGR of 5.00% over the forecast period of 2019-2025.


Market Insight

Human papillomavirus vaccine is inactivated human papillomavirus-like particles which protects against four major types of human papillomaviruses. This vaccine protects majorly against warts and cervical cancer. Human papillomavirus causes disease such as cancer of cervix, vagina, vulva, penis, anus and oropharyngeal cancer. Human papillomavirus vaccine is injected to people of age group in-between 11 to 26, before getting sexually involved. There are only three types of vaccines available in the market for human papillomavirus namely bivalent, quadrivalent and nonavalent.

 

Growing incidences of cervical cancer across the globe is driving the growth of the human papillomavirus vaccine market. Cervical cancer is the second leading cause of cancer caused by women. According to the CDC, human papillomavirus is the main cause of cervical cancer. Cervical cancer can be prevented by vaccination. Gardasil 4v, Gardasil 9v, and Cervarix 2v are the vaccines used in the prevention of human papillomavirus. Additionally, there is an increase in demand for human papillomavirus vaccine for cervical cancer but demand doesn’t meet the supply of vaccines. Hence restraining the growth of the human papillomavirus vaccine market. High unfulfilled needs of human papillomavirus vaccine are likely to create lucrative opportunities for key manufacturers in the global human papillomavirus vaccine market. furthermore, research and development activities in the human papillomavirus vaccines are also providing growth opportunities for the market in the coming years.

 

Geographically, North America is expected to hold maximum share in the growth of human papillomavirus vaccine. According to the CDC in the U.S., 12,000 women diagnosed with cervical cancer and 4000 women died of cervical cancer. This is estimated to boost the growth of the human papillomavirus vaccine market. Europe has the second largest share in the growth of human papillomavirus vaccine market as there is growing awareness about the papillomavirus vaccine. Furthermore, Asia Pacific is the fastest growing region in this market. The major contributors in this region are China and India.


Global Human Papillomavirus Vaccine Market 

 

Segment Covered

The report on the global human papillomavirus vaccine market covers segments such as product type, indication, and distribution channel. On the basis of product type, the sub-markets include gardasils, gardasil 9, and cervarix. On the basis of indication, the sub-markets include cervical cancer, cancer, vaginal cancer, vulvar cancer, oropharyngeal cancer, and other indications. On the basis of the distribution channel, the sub-markets include hospitals, clinics, and government entities.

 
Companies Profiled:

The report provides profiles of the companies in the market such as Merck & Co., Inc., GlaxoSmithKline plc., Sanofi S.A., Johnson & Johnson, Inovio Pharmaceuticals Inc., Pfizer Inc., Bayer AG, Nuron Biotech Inc., and EyeGene Inc.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of human papillomavirus vaccine market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

The Infinium Advantages

Analyst Support

Get free analyst support for the queries before and post purchasing report.

Customer Satisfaction

Be assured of 100% customer satisfaction about the research and get 24X7 customer support.

400% Growth

Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.

Related Reports

sign up for our newsletter